Effects of long-term vitamin D and n -3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial
Conclusions/interpretationAmong adults with type 2 diabetes, supplementation with vitamin D3 orn-3 fatty acids did not reduce IL-6, hsCRP or NT-proBNP over 5 years.Trial registrationClinicalTrials.gov NCT01684722FundingThe study was funded by grant R01DK088762 from the National Institute of Diabetes and Digestive and Kidney Diseases.Graphical abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Cancer & Oncology | Cardiology | Cardiovascular | Computers | Diabetes | Diabetes Type 2 | Endocrinology | Grants | Heart | Omega 3 | Study | Urology & Nephrology | Vitamin D | Vitamin D3 | Vitamins | Women